Interactive effect of oral anti-hyperglycaemic or anti–hypertensive drugs on the inhibitory and bactericidal activity of first line anti-TB drugs against M. tuberculosis
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0292397 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Priyanka Trivedi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Biochemistry and Structural Biology Division, Central Drug Research Institute, Lucknow, UP, India. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Tuberculosis, Hypertension, Diabetes Mellitus. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Co-existence of life style disorders, like, Diabetes or Hypertension, increases risk of, treatment failure, deaths and developing drug-resistant TB. Concomitant administration of drugs to treat dual/multi-morbidities may alter their effectiveness, in additive/synergistic or adverse/antagonistic manner. We evaluated interactive effect of 7 anti-hyperglycaemic (HG) and 6 anti-hypertensive (HT) drugs on the inhibitory (MICs) and bactericidal (% killing of intracellular bacilli) activities of anti-TB drugs, Isoniazid (INH), Rifampicin (RFM), Ethambutol (EMB) and Streptomycin (STR) against M . tuberculosis . Five anti-HG drugs, namely, Acarbose, Acetohexamide, Glyburide, Repaglinide and Sitagliptin imparted either ‘additive’ or ‘no effect’ on the activities (inhibition or % killing) of all the four anti-TB drugs, as evident by their lower FICs (Fractional Inhibitory concentrations) and higher bacterial killing in combination. Metformin and Rosiglitazone, however, exerted adverse effect on the Ethambutol (FICs >2.0). All the six anti-HT drugs, namely, Atenolol, Hydrochlorothiazide, Ramipril, Valsartan, Nifedipine and Verapamil exerted either ‘additive’/’synergistic’ or ‘no effect’ on the activities of anti-TB drugs. These findings may help clinicians to select safe and helpful anti-HG or anti-HT drugs for TB patients, if, suffering with diabetes or hypertension like co-morbidities and receiving DOTs (a set regimen for the treatment of TB based on the WHO guidelines).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Biochemistry and Structural Biology Division, Central Drug Research Institute, Lucknow, UP, India.
ORCID-Profile: Vinita Chaturvedi
Zitieren
APA
Trivedi, P., & Chaturvedi, V. (2023). Interactive effect of oral anti-hyperglycaemic or anti–hypertensive drugs on the inhibitory and bactericidal activity of first line anti-TB drugs against M. tuberculosis. PLOS ONE. https://doi.org/10.1371/journal.pone.0292397
Vancouver
Trivedi P, Chaturvedi V. Interactive effect of oral anti-hyperglycaemic or anti–hypertensive drugs on the inhibitory and bactericidal activity of first line anti-TB drugs against M. tuberculosis. PLOS ONE. 2023. doi:10.1371/journal.pone.0292397
BibTeX
@article{Trivedi2023,
author = {Trivedi, Priyanka and Chaturvedi, Vinita},
title = {Interactive effect of oral anti-hyperglycaemic or anti–hypertensive drugs on the inhibitory and bactericidal activity of first line anti-TB drugs against M. tuberculosis},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0292397}
}
EUVIMED